Effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i) among people with CKD (Search date: April 2023)
PubMed 
1. Randomized controlled trial[pt]
2. Controlled clinical trial[pt]
3. Randomized[tiab]
4. Placebo[tiab]
5. “Clinical trials as topic”[mh:noexp]
6. Randomly[tiab]
7. Trial[ti]
8. #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7
9. “Sodium-glucose transporter 2 inhibitors”[mh]
10. SGLT2[tiab] OR SGLT-2[tiab]
11. “Sodium-glucose transporter 2”[mh]
12. "Sodium-glucose co-transporter”[tiab] OR “sodium-glucose cotransporter”[tiab]
13. Canagliflozin[tiab] OR dapagliflozin[tiab] OR empagliflozin[tiab] OR ertugliflozin[tiab] OR ipragliflozin[tiab] OR luseogliflozin[tiab] OR remogliflozin[tiab] OR sotagliflozin[tiab] OR tofogliflozin[tiab]
14. #9 OR #10 OR #11 OR #12 OR #13
15. #8 AND #14
16. Animals[mh] NOT humans[mh]
17. #15 NOT #16